Announcements Trials
Browse Landscape

Phase

Phase 3 49Phase 2 37Phase 1 7Phase 1/2 5Phase NA 3Phase 2/3 3Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 49INDUSTRY 6NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

sintilimab 1diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine 1Vincristine 1Sevoflurane 1Rituximab 1Propofol 1Pleurodesis 1Mitoxantrone 1Methotrexate 1Introns 1Interferon alpha-2 1Idarubicin 1Gastrointestinal Microbiome 1Drug Therapy 1Docetaxel 1Dexamethasone 1Dasatinib 1Danazol 1Cytarabine 1Clorazepate Dipotassium 1Carboplatin 1Anesthesia, Epidural 123-valent pneumococcal capsular polysaccharide vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NETWORK × Dexamethasone × Clear all
NCT00411541 2006-12-14

Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia

International BFM Study Group

Phase 4 Completed
2,600 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡